Roth Capital Downgrades China Cord Blood To Neutral By: Benzinga via Benzinga June 26, 2015 at 09:07 AM EDT Roth Capital downgraded China Cord Blood Corp (NYSE: CO) from Buy to Neutral. The price target for China Cord Blood has been raised ... Read More >>